GI Clinical Research Studies

Gastrointestinal disorders can cause pain, discomfort, bloating and other discomforting symptoms. There are many different types of GI disorders including gastroparesis, constipation, and bloating. The current GI study at Clinical Research Center of Alabama focuses on the treatment and relief of gastroparesis. Study medication is provided at absolutely no cost, and with no insurance needed. You may also be reimbursed for your time and travel and will receive care from a physician affiliated with Clinical Research Center of Alabama.
For more information on any of the following eczema clinical research studies, please contact Will O’Donnell by calling 205.209.4179 or emailing [email protected]


Ages 19-<80

This study is being done to see how safe the investigational new drug, AK002 is, and how it affects the number of eosinophils in the duodenum. AK002 is an intravenous drug, meaning that it is given through a needle placed in your vein. AK002 is a humanized antibody, which is a protein produced by the body’s immune system that recognizes and helps fight infections and other foreign substances in the body.


Ages 19-65

The purpose of this study is to assess an investigational drug called etrasimod in the treatment of eosinophilic esophagitis (EoE). This study is being done to find out which dose of etrasimod works best and which is the safest dose for people with EoE. The study will also look at how etrasimod works, and whether it will reduce the number of eosinophils in the esophagus and help improve the pain or difficulty of swallowing in people with EoE.

Become a Participant in our GI Studies

If you’re interested in participating in a clinical research study at the Clinical Research Center of Alabama, call 205.209.4100 to speak with an experienced coordinator or fill out the contact form below.